ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

NCT05672836 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1040

Enrollment

OTHER

Sponsor class

Conditions

Aortic Valve Stenosis
Heart Failure

Interventions

DRUG: Enavogliflozin
DRUG: Standard-of-Care

Sponsor

Duk-Woo Park, MD

Collaborators

[object Object]
[object Object]